Literature DB >> 27174008

[Bronchoscopic lung volume reduction in emphysema without collateral ventilation : STELVIO trial].

F J Herth1, S Nitschmann2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27174008     DOI： 10.1007/s00108-016-0049-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  5 in total

1.  [Bronchoscopic lung volume reduction. BeLieVeR-HIFi study].

Authors:  W Gesierich; J Behr; S Nitschmann
Journal:  Internist (Berl)       Date:  2016-02       Impact factor: 0.743

2.  Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment.

Authors:  Felix J F Herth; Ralf Eberhardt; Daniela Gompelmann; Joachim H Ficker; Manfred Wagner; Lars Ek; Bernd Schmidt; Dirk-Jan Slebos
Journal:  Eur Respir J       Date:  2012-05-03       Impact factor: 16.671

3.  A randomized study of endobronchial valves for advanced emphysema.

Authors:  Frank C Sciurba; Armin Ernst; Felix J F Herth; Charlie Strange; Gerard J Criner; Charles H Marquette; Kevin L Kovitz; Richard P Chiacchierini; Jonathan Goldin; Geoffrey McLennan
Journal:  N Engl J Med       Date:  2010-09-23       Impact factor: 91.245

4.  Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema--potential mechanisms, treatment algorithm, and case examples.

Authors:  Arschang Valipour; Dirk-Jan Slebos; Hugo G de Oliveira; Ralf Eberhardt; Lutz Freitag; Gerard J Criner; Felix J F Herth
Journal:  Respiration       Date:  2014-04-24       Impact factor: 3.580

5.  Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema.

Authors:  Daniela Gompelmann; Felix J F Herth; Dirk Jan Slebos; Arschang Valipour; Armin Ernst; Gerard J Criner; Ralf Eberhardt
Journal:  Respiration       Date:  2014-04-30       Impact factor: 3.580
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.